Zhitong App learned that on March 13th, Weiyi and TENCENT (00700) signed a strategic cooperation agreement in Shenzhen, integrating the accumulation and application scenarios of TENCENT and Weiyi in the field of artificial intelligence. They will jointly promote medical large models, focusing on the &#34;management of six diseases&#34; (tumors, cardiovascular and cerebrovascular diseases, respiratory diseases, metabolism, reproductive medicine, and geriatric diseases) to develop specialized intelligent products. With the help of artificial intelligence, they aim to promote the synergy of the three medical sectors and create a demonstration city for the application of medical artificial intelligence in China. This cooperation is a proactive move by TENCENT to promote the application of artificial intelligence in the medical and health industry, and it is also an important step for Weiyi to implement the &#34;medical large model&#34; and upgrade the medical AI application scenarios in its &#34;intelligent hospital.&#34;
Witnessed by Weiyi Group's founder and chairman Liao Jieyuan, CITIC Securities' chairman Tang Liang, TENCENT's senior executive vice president and CEO of Cloud and Smart Industries Business Group Tang Daosheng, TENCENT Health's president Wu Wenda, TENCENT Cloud's vice president Gu Wei, and others, the signing ceremony took place. Zhang Jun, President of Weiyi Holdings, and Zhang Yu, Vice President of TENCENT Health, signed the strategic cooperation agreement on behalf of both parties. Yan Jinhong, Senior Vice President of Weiyi Holdings and President of Weiyi Cloud Platform, and Zhou Ning, General Manager of TENCENT Cloud's East China Region, signed the cloud platform cooperation agreement on behalf of both parties.
<img src="https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20240314/1710396393990306.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="111.png" original-src="https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20240314/1710396393990306.png"/>
Image | Weiyi and TENCENT sign a strategic cooperation agreement
2024 is considered the first year of the application of AI large models, and the medical and health industry is seen as the first major market for large model applications, attracting attention. Medical large models need to have cutting-edge capabilities in technology depth, scenario adaptability, and data quality. The research and training difficulty and application value are far higher than in other fields.
TENCENT and Weiyi have deep accumulation in AI technology research and development, medical application scenarios, and other aspects. In recent years, Weiyi has deeply integrated digital technology with medical service scenarios, achieving the large-scale application of artificial intelligence technology in its intelligent hospitals, health communities, and other major medical service scenarios. The platform has accumulated over 400 million dialogue data, more than 200 million medical cases, and data from over 200,000 doctors. With the support of digital technology, for example, in Tianjin, the revenue of a single intelligent hospital has reached the scale of a large Grade III hospital. This cooperation between the two parties will effectively promote the application scenarios of large model technology in the medical field, the organic combination of big data, and accelerate the development of new quality productivity in medical and health.
AI is one of TENCENT's core strategies. As a global leader in cloud computing, data security, artificial intelligence, and other technology products and services, TENCENT has massive public cloud computing resources and leading key technologies such as large models and digital humans.
<img src="https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20240314/1710396403320369.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="222.png" original-src="https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20240314/1710396403320369.png"/>
The collaboration between WeDoctor and TENCENT on the cloud platform was officially announced. They have agreed to conduct comprehensive and in-depth cooperation using WeDoctor's platform and demonstration application scenarios in Tianjin, Sanming, Shanghai, and other locations. The collaboration aims to establish a leading medical big data model brand and medical AI digital human; jointly build a platform for managing six diseases, establish a national digital healthcare center, create a high-standard urban digital health community, develop a medical health intelligent brain, medical big data platform, chronic disease and health management service platform, and construct a unified digital foundation to provide industry-wide joint solutions in an intensive operational service system.
Ning Guang, academician of the Chinese Academy of Engineering and President of Shanghai Ruijin Hospital, expressed in a video speech that the in-depth application of AI requires the integration of cutting-edge medical technology, large-scale application scenarios, and artificial intelligence technology. The goals and advantages of Shanghai Ruijin Hospital, TENCENT, and WeDoctor are highly complementary, which can drive the development of domestically leading and globally recognized medical big data models, promoting high-quality industry development. Previously, Shanghai Ruijin Hospital and WeDoctor have established in-depth cooperation in cutting-edge medical technology applications, intelligent triage of difficult diseases, and digital &#34;management of six diseases.&#34; Shanghai Ruijin Hospital and Sanming City, Fujian Province, are jointly promoting the construction of a &#34;management center for six diseases&#34; supported by digitalization.
The application of medical AI technology in real medical scenarios has brought about a qualitative improvement. The adoption rate of AI-assisted diagnosis by doctors in WeDoctor's intelligent hospital has exceeded 86%, with a daily diagnosis and treatment volume of over 40,000 people, effectively improving patient health indicators and saving medical insurance funds. Yan Jinhong introduced the progress plan of this collaboration, based on big data models and digital human technology, focusing on the &#34;six diseases&#34; to promote the upgrade of products such as &#34;intelligent doctors,&#34; &#34;intelligent health managers,&#34; and &#34;health digital humans,&#34; substantially enhancing the diagnosis and treatment capabilities of grassroots doctors nationwide, providing users with integrated services throughout the entire lifecycle of prevention, screening, diagnosis, treatment, and management. The innovative outcomes of the three parties will form standardized capabilities and products for specific diseases, supporting the implementation and digital upgrade of a closely-knit national medical community.
Wu Wenda, President of TENCENT Health, pointed out that based on the long-term cooperation between TENCENT and WeDoctor, WeDoctor has evolved into a digital health platform with broad and in-depth medical scenarios, vigorously promoting the deep application of AI. They have always adhered to the mission of serving the health needs of the people as the primary goal, aligning closely with TENCENT's vision of &#34;technology for good.&#34; It is believed that the collaboration between the two parties can contribute to enhancing the service capabilities of grassroots medical care and supporting the deepening of medical reform.

00700

TCEHY

Tencent and WeDoctor have collaborated in the field of artificial intelligence to launch a large medical model focusing on six major diseases. With the assistance of AI, they aim to promote the synergy of three medical sectors and establish a demonstration city for medical AI applications in China. This collaboration is a significant step for Tencent in promoting the application of medical AI and a crucial upgrade for WeDoctor's intelligent hospitals.

Tencent and WeDoctor jointly promote the "Medical Big Model", marking a milestone for medical AI.